Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
J Pediatr. 2020 Dec;227:268-273. doi: 10.1016/j.jpeds.2020.08.033. Epub 2020 Aug 14.
To evaluate the ethnic distribution of Israeli patients with the syndrome of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA).
The medical records of patients with PFAPA attending 2 pediatric tertiary medical centers in Israel from March 2014 to March 2019 were retrospectively reviewed. Patients with concomitant familial Mediterranean fever were excluded. Ethnicity was categorized as Mediterranean, non-Mediterranean, and multiethnic. Findings were compared with patients with asthma under treatment at the same medical centers during the same period.
The cohort included 303 patients with PFAPA and 475 with asthma. Among the patients with PFAPA, 178 (58.7%) were of Mediterranean descent (Sephardic Jews or Israeli Arabs), 96 (33.0%) were multiethnic, and 17 (5.8%) were of non-Mediterranean descent (all Ashkenazi Jews). Patients with PFAPA had a significantly higher likelihood of being of Mediterranean descent than the patients with asthma (58.7% vs 35.8%; P < .0001). The Mediterranean PFAPA subgroup had a significantly earlier disease onset than the non-Mediterranean subgroup (2.75 ± 1.7 vs 3.78 ± 1.9 years, P < .04) and were younger at disease diagnosis (4.77 ± 2.3 vs 6.27 ± 2.9 years, P < .04).
PFAPA was significantly more common in patients of Mediterranean than non-Mediterranean descent. Further studies are needed to determine the genetic background of these findings.
评估周期性发热、口疮性口炎、咽炎和淋巴结炎(PFAPA)综合征以色列患者的种族分布。
回顾性分析 2014 年 3 月至 2019 年 3 月在以色列 2 家儿科三级医疗中心就诊的 PFAPA 患者的病历。排除同时患有家族性地中海热的患者。将种族分为地中海、非地中海和多种族。将结果与同期在同一医疗中心接受治疗的哮喘患者进行比较。
该队列包括 303 例 PFAPA 患者和 475 例哮喘患者。在 PFAPA 患者中,178 例(58.7%)为地中海血统(塞法迪犹太人或以色列阿拉伯人),96 例(33.0%)为多种族,17 例(5.8%)为非地中海血统(均为阿什肯纳兹犹太人)。PFAPA 患者为地中海血统的可能性明显高于哮喘患者(58.7%比 35.8%;P<0.0001)。地中海 PFAPA 亚组的疾病发病年龄明显早于非地中海亚组(2.75±1.7 比 3.78±1.9 岁,P<0.04),且疾病诊断时年龄更小(4.77±2.3 比 6.27±2.9 岁,P<0.04)。
PFAPA 在地中海血统患者中明显更为常见。需要进一步研究确定这些发现的遗传背景。